Arcturus Therapeutics Holdings (ARCT) Assets Average (2019 - 2026)

Arcturus Therapeutics Holdings has reported Assets Average for 8 years, with the latest figure at $258.3 million in Q1 2026.

• For the quarter ending Q1 2026, Assets Average fell 23.57% year-over-year to $258.3 million; the trailing twelve-month figure through Mar 2026 stood at $258.3 million (down 23.57% YoY), and the FY2025 full-year result was $307.6 million, down 20.46% from the prior year.
• Assets Average for Q1 2026 stood at $258.3 million, down from $276.7 million in the prior quarter.
• The five-year high for Assets Average was $460.6 million in Q1 2023, with the low at $258.3 million in Q1 2026.
• Historically, Assets Average has averaged $367.5 million across 5 years, with a median of $367.4 million in 2022.
• Annual changes were most pronounced in 2022 — Assets Average dropped 28.61% — and 2023, when it surged 40.86%.
• Arcturus Therapeutics Holdings' Assets Average stood at $372.0 million in 2022, then gained by 19.23% to $443.5 million in 2023, then retreated by 19.43% to $357.4 million in 2024, then dropped by 22.56% to $276.7 million in 2025, then fell by 6.67% to $258.3 million in 2026.
• The last three Assets Average figures came in at $258.3 million (Q1 2026), $276.7 million (Q4 2025), and $295.8 million (Q3 2025), per Business Quant data.